BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

549 related articles for article (PubMed ID: 25926150)

  • 1. Survival in patients with breast cancer with bone metastasis: a Danish population-based cohort study on the prognostic impact of initial stage of disease at breast cancer diagnosis and length of the bone metastasis-free interval.
    Cetin K; Christiansen CF; Sværke C; Jacobsen JB; Sørensen HT
    BMJ Open; 2015 Apr; 5(4):e007702. PubMed ID: 25926150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic Value of Brain Metastasis-Free Interval in Patients with Breast Cancer Brain Metastases.
    Hulsbergen AFC; Lamba N; Claes A; Kavouridis VK; Lin NU; Smith TR; Verhoeff JJC; Broekman MLD
    World Neurosurg; 2019 Aug; 128():e157-e164. PubMed ID: 31035019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival after bone metastasis by primary cancer type: a Danish population-based cohort study.
    Svensson E; Christiansen CF; Ulrichsen SP; Rørth MR; Sørensen HT
    BMJ Open; 2017 Sep; 7(9):e016022. PubMed ID: 28893744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Site of metastasis and breast cancer mortality: a Danish nationwide registry-based cohort study.
    Ording AG; Heide-Jørgensen U; Christiansen CF; Nørgaard M; Acquavella J; Sørensen HT
    Clin Exp Metastasis; 2017 Jan; 34(1):93-101. PubMed ID: 27718076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival in breast cancer patients with bone metastases and skeletal-related events: a population-based cohort study in Denmark (1999-2007).
    Yong M; Jensen AÖ; Jacobsen JB; Nørgaard M; Fryzek JP; Sørensen HT
    Breast Cancer Res Treat; 2011 Sep; 129(2):495-503. PubMed ID: 21461730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone metastasis, skeletal-related events, and mortality in lung cancer patients: a Danish population-based cohort study.
    Cetin K; Christiansen CF; Jacobsen JB; Nørgaard M; Sørensen HT
    Lung Cancer; 2014 Nov; 86(2):247-54. PubMed ID: 25240518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast cancer recurrence, bone metastases, and visceral metastases in women with stage II and III breast cancer in Denmark.
    Cronin-Fenton D; Kjærsgaard A; Nørgaard M; Amelio J; Liede A; Hernandez RK; Sørensen HT
    Breast Cancer Res Treat; 2018 Jan; 167(2):517-528. PubMed ID: 28948396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thirty-Year Trends of Survival and Time-Varying Effects of Prognostic Factors in Patients With Metastatic Breast Cancer-A Single Institution Experience.
    Rogoz B; Houzé de l'Aulnoit A; Duhamel A; Houzé de l'Aulnoit D
    Clin Breast Cancer; 2018 Jun; 18(3):246-253. PubMed ID: 28988656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic outcomes in advanced breast cancer: the metastasis-free interval is important.
    Shen T; Gao C; Zhang K; Siegal GP; Wei S
    Hum Pathol; 2017 Dec; 70():70-76. PubMed ID: 29031733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive factors of survival time of breast cancer in kurdistan province of Iran between 2006-2014: a cox regression approach.
    Karimi A; Delpisheh A; Sayehmiri K; Saboori H; Rahimi E
    Asian Pac J Cancer Prev; 2014; 15(19):8483-8. PubMed ID: 25339051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors affecting survival in breast cancer patients following bone metastasis.
    Yavas O; Hayran M; Ozisik Y
    Tumori; 2007; 93(6):580-6. PubMed ID: 18338493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mortality after contralateral breast cancer in Denmark.
    Langballe R; Frederiksen K; Jensen MB; Andersson M; Cronin-Fenton D; Ejlertsen B; Mellemkjær L
    Breast Cancer Res Treat; 2018 Sep; 171(2):489-499. PubMed ID: 29948403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathological factors associated with survival in patients with breast cancer brain metastasis.
    Li R; Zhang K; Siegal GP; Wei S
    Hum Pathol; 2017 Jun; 64():53-60. PubMed ID: 28428107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors, prognostic factors, and nomograms for bone metastasis in patients with newly diagnosed infiltrating duct carcinoma of the breast: a population-based study.
    Huang Z; Hu C; Liu K; Yuan L; Li Y; Zhao C; Hu C
    BMC Cancer; 2020 Nov; 20(1):1145. PubMed ID: 33238981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of bone metastasis from breast cancer.
    Yamashita K; Koyama H; Inaji H
    Clin Orthop Relat Res; 1995 Mar; (312):89-94. PubMed ID: 7634621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Skeletal related events, bone metastasis and survival of prostate cancer: a population based cohort study in Denmark (1999 to 2007).
    Nørgaard M; Jensen AØ; Jacobsen JB; Cetin K; Fryzek JP; Sørensen HT
    J Urol; 2010 Jul; 184(1):162-7. PubMed ID: 20483155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of comorbidity on mortality: a cohort study of 62,591 Danish women diagnosed with early breast cancer, 1990-2008.
    Land LH; Dalton SO; Jensen MB; Ewertz M
    Breast Cancer Res Treat; 2012 Feb; 131(3):1013-20. PubMed ID: 22002567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mortality rates among early-stage hormone receptor-positive breast cancer patients: a population-based cohort study in Denmark.
    Christiansen P; Bjerre K; Ejlertsen B; Jensen MB; Rasmussen BB; Lænkholm AV; Kroman N; Ewertz M; Offersen B; Toftdahl DB; Møller S; Mouridsen HT;
    J Natl Cancer Inst; 2011 Sep; 103(18):1363-72. PubMed ID: 21881042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain Metastasis in Colorectal Cancer Patients: Survival and Analysis of Prognostic Factors.
    Michl M; Thurmaier J; Schubert-Fritschle G; Wiedemann M; Laubender RP; Nüssler NC; Ruppert R; Kleeff J; Schepp W; Reuter C; Löhe F; Karthaus M; Neumann J; Kirchner T; Engel J; Heinemann V
    Clin Colorectal Cancer; 2015 Dec; 14(4):281-90. PubMed ID: 26123495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognosis of metastatic breast cancer subtypes: the hormone receptor/HER2-positive subtype is associated with the most favorable outcome.
    Lobbezoo DJ; van Kampen RJ; Voogd AC; Dercksen MW; van den Berkmortel F; Smilde TJ; van de Wouw AJ; Peters FP; van Riel JM; Peters NA; de Boer M; Borm GF; Tjan-Heijnen VC
    Breast Cancer Res Treat; 2013 Oct; 141(3):507-14. PubMed ID: 24104881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.